Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Cell and Gene Therapy Catapult is an independent innovation and technology organization established to accelerate the growth of the UK cell and gene therapy industry. It provides specialized infrastructure, including large-scale GMP manufacturing centers and sophisticated analytical laboratories, to help companies bridge the gap between early-stage research and full-scale commercialization. By offering technical expertise, regulatory guidance, and collaborative manufacturing space, the organization reduces the risk and cost associated with developing advanced therapies. Its mission is to ensure that the UK remains a global leader in the development, delivery, and commercialization of life-changing cell and gene treatments.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cell and Gene Therapy Manufacturing.